ES8707296A1 - Un metodo para producir anticuerpos monoclonales humanos - Google Patents

Un metodo para producir anticuerpos monoclonales humanos

Info

Publication number
ES8707296A1
ES8707296A1 ES555741A ES555741A ES8707296A1 ES 8707296 A1 ES8707296 A1 ES 8707296A1 ES 555741 A ES555741 A ES 555741A ES 555741 A ES555741 A ES 555741A ES 8707296 A1 ES8707296 A1 ES 8707296A1
Authority
ES
Spain
Prior art keywords
exotoxin
monoclonal antibodies
human monoclonal
pseudomonas aeruginosa
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES555741A
Other languages
English (en)
Other versions
ES555741A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genetic Systems Corp
Original Assignee
Genetic Systems Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetic Systems Corp filed Critical Genetic Systems Corp
Publication of ES8707296A1 publication Critical patent/ES8707296A1/es
Publication of ES555741A0 publication Critical patent/ES555741A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1214—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE ANTICUERPOS MONOCLONALES HUMANOS ESPECIFICOS PARA LA EPOTOXINA A DE PSEUDOMONAS AERUGINOSA. CONSISTE EN INMORTALIZAR CON VIRUS DE EPSTEIN-BARR CELULAS B HUMANAS DE UN PACIENTE EXPUESTAS A ANTIGENOS DE LA OXOTOXINA A DE PSEUDOMONAS AERUGIONSA; SEPARAR DE ESTAS CELULAS LAS LINEAS CELULARES QUE SEGREGAN ANTICUERPOS MONOCLONALES REACTIVOS CON LA EXOTOXINA A; COMPROBAR ESTOS ANTICUERPOS; CULTIVAR UNA LINEA CELULAR PRODUCTORA DEL ANTICUERPO NEUTRALIZANTE; Y RECUPERAR LOS ANTICUERPOS SEGREGADOS POR LA MISMA. ESTOS ANTICUERPOS TIENEN APLICACIONES FARMACOLOGICAS PARA EL TRATAMIENTO DE INFECCIONES BACTERIANAS.
ES555741A 1985-06-06 1986-06-05 Un metodo para producir anticuerpos monoclonales humanos Expired ES8707296A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US74217085A 1985-06-06 1985-06-06

Publications (2)

Publication Number Publication Date
ES8707296A1 true ES8707296A1 (es) 1987-07-16
ES555741A0 ES555741A0 (es) 1987-07-16

Family

ID=24983768

Family Applications (1)

Application Number Title Priority Date Filing Date
ES555741A Expired ES8707296A1 (es) 1985-06-06 1986-06-05 Un metodo para producir anticuerpos monoclonales humanos

Country Status (12)

Country Link
EP (1) EP0229107A4 (es)
JP (1) JPS63500035A (es)
AU (2) AU5991786A (es)
DK (1) DK59387D0 (es)
ES (1) ES8707296A1 (es)
FI (1) FI870482A (es)
HU (1) HU205630B (es)
IE (1) IE861494L (es)
IL (1) IL79010A0 (es)
NO (1) NO174003C (es)
WO (1) WO1986007382A1 (es)
ZA (1) ZA864196B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK172840B1 (da) * 1986-07-03 1999-08-09 Genetic Systems Corp Monoklonale antistoffer mod Pseudomonas aeruginosa flagella, farmaceutiske præparater indeholdende sådanne antistoffer og c
JPS6463374A (en) * 1987-09-03 1989-03-09 Agency Ind Science Techn Human monoclonal antibody, antibody-forming cell, antibody-forming hybridoma and production of antibody
US5126259A (en) * 1987-12-24 1992-06-30 Takeda Chemical Industries, Ltd. Human b. lymphoblastoid cell, hybridoma, antibody and production of antibody
CA1341375C (en) * 1988-10-12 2002-07-09 Baxter International Inc. Compositions and methods for the treatment and prevention of gram-negative bacterial infections
EP0382031A3 (en) * 1989-02-10 1991-06-26 Miles Inc. Monoclonal antibodies in immune serum globulin
EP2393515A1 (en) * 2009-02-04 2011-12-14 Kalobios Pharmaceuticals, Inc. Combination antibiotic and antibody therapy for the treatment of pseudomonas aeruginosa infection

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4464465A (en) * 1982-04-05 1984-08-07 Genetic Systems Corporation Cell-driven viral transfer in eukaryotes
AU567693B2 (en) * 1982-09-30 1987-12-03 University Of Rochester Human monoclonal antibodies against bacterial toxins
US5179018A (en) * 1983-10-14 1993-01-12 Centocor, Inc. Mamalian monoclonal antibodies against endotoxin of gram-negative bacteria
GB8422649D0 (en) * 1984-09-07 1984-10-10 Technology Licence Co Ltd Monoclonal antibodies
JP2691708B2 (ja) * 1984-09-26 1997-12-17 住友製薬株式会社 ヒトモノクローナル抗体およびその製法

Also Published As

Publication number Publication date
NO870457L (no) 1987-02-05
EP0229107A1 (en) 1987-07-22
IE861494L (en) 1986-12-06
WO1986007382A1 (en) 1986-12-18
NO174003B (no) 1993-11-22
FI870482A0 (fi) 1987-02-05
JPS63500035A (ja) 1988-01-07
DK59387A (da) 1987-02-05
FI870482A (fi) 1987-02-05
IL79010A0 (en) 1986-09-30
AU5991786A (en) 1987-01-07
ZA864196B (en) 1987-02-25
HUT42135A (en) 1987-06-29
ES555741A0 (es) 1987-07-16
AU6658390A (en) 1991-03-14
EP0229107A4 (en) 1987-11-09
NO174003C (no) 1994-03-02
DK59387D0 (da) 1987-02-05
HU205630B (en) 1992-05-28

Similar Documents

Publication Publication Date Title
NO2014016I2 (no) Dimetylfumarat
HUP9901144A2 (hu) Hatóanyagként klopidogrel és egy antitrombotikum új kombinációját tartalmazó gyógyszerkészítmények
BG91270A (bg) Антивирусно и антибактериално средство и метод за използването му
MY102365A (en) Di-t-butylphenol compounds.
MX9603596A (es) Perfluoropolieteres o composiciones de los mismos para prevencion y tratamiento de infecciones virales topicas.
DE69230798T2 (de) Rekombinante immuntoxine
ATE188873T1 (de) Tris-platin-komplexe
DE69311541D1 (de) Kosmetische oder pharmazeutische zusammensetzungen zur topischen anwendung die deacylierten glycerophospholipide enthalten
ES2013321A6 (es) Un metodo de produccion de anticuerpos monoclonales
ES8707296A1 (es) Un metodo para producir anticuerpos monoclonales humanos
IL67940A0 (en) 2,3-diaryl-5-halo-thiophenes,their preparation and pharmaceutical compositions containing them
PT90661A (pt) Processo para a preparacao de composicoes farmaceuticas contendo inibidores da enzima conversora de angiotensina e moduladores de canal de potassio
ES2062145T3 (es) 1,8-naftiridinas substituidas.
AU564439B2 (en) Pharmaceutical compositions containing l-alpha- glycerylphosphorylcholine
ES2181915T3 (es) Ctla-8 en combinacionpn con g-csf y il-6, y uso de ctla-8 para tratar infecciones.
AU559768B2 (en) Aluminium or zinc panthenolate and their use for treating wounds
DE3364240D1 (en) Cytotoxic medicine containing at least one immune toxine and chloroquine
AUPQ647600A0 (en) Pharmaceutical gel composition
MY110998A (en) Antibiotic combination
AU6877587A (en) Expellants of phytopathogenic microbes
ES8707955A1 (es) Un procedimiento para la preparacion pirazolidinonas biciclicas'
FR2707492B1 (fr) Nouvelles compositions cosmétiques ou dermatologiques renfermant les ribosomes, préparation des ribosomes, préparation desdites compositions et leur application.
EP0190860A3 (en) 6-chloro-3-methyl-1h-2,3,4,5-tetrahydro-3-benzazepine-n-oxide and medical compositions using it
GR3005231T3 (es)
IL61548A (en) Synergistic analgesic pharmaceutical compositions comprising aspirin and heptaminol

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970505